BRIEF-Gan & Lee Pharmaceuticals Signs Framework Agreement
Reuters2025-09-23
BRIEF-Gan & Lee Pharmaceuticals Signs Framework Agreement
Sept 23 (Reuters) - Gan & Lee Pharmaceuticals 603087.SS:
SAYS IT SIGNED SUPPLY FRAMEWORK AGREEMENT WITH BIOMM WORTH EXPECTED AT LEAST 3 BILLION YUAN ($421.87 million)
Source text
Further company coverage: 603087.SS
($1 = 7.1112 Chinese yuan renminbi)
(Reporting by Beijing Newsroom)
((yukun.zhang@thomsonreuters.com;))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments